Garen Manvelian

Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial

Amy Damask, Philippe Gabríel Steg, Gregory G. Schwartz et al. · Circulation · 2019 · 232 citations · Full text

Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial

Carlos A. Molina, Andrew D. Barreto, Georgios Tsivgoulis et al. · Annals of Neurology · 2009 · 226 citations

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial

Patrick M. Moriarty, Klaus G. Parhofer, Stephan P. Babirak et al. · European Heart Journal · 2016 · 194 citations · Full text

PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia

Sophie J. Bernelot Moens, Annette E. Neele, Jeffrey Kroon et al. · European Heart Journal · 2017 · 187 citations · Full text

A Comparison of Depodur???, a Novel, Single-Dose Extended-Release Epidural Morphine, with Standard Epidural Morphine for Pain Relief After Lower Abdominal Surgery

David R. Gambling, Thomas L. Hughes, Gavin Martin et al. · Anesthesia & Analgesia · 2005 · 147 citations

Pca Fentanyl, Lower Abdominal Surgery, Ms Patients +15